Houston Addiction Treatment Study Focuses on Meth

HOUSTON - June 25, 2018 - PRLog -- A new form of methamphetamine addiction treatment is currently being applied as a trial in Houston.

An experimental drug that could treat addiction, called ADAPT-2, is being looked at in Houston and in six cities across the country. The experimental drug is a mixture of two different medications that are aimed at obstructing the euphoria conjured by meth and reduce the withdrawal symptoms.

The University of Texas Health Science Center at Houston (UTHealth) is where the experimental trial is being led. Their goal is to educated the health science professionals, obtain new information about advances in the medical field and formulate the best ways of medical care.

If their clinical trial succeeds, the Food and Drug Administration (FDA) could approve it for meth addiction treatment.

According to half of 18 Department Enforcement Agency (DEA) offices, methamphetamine is the biggest drug threat in Texas.

There were 715 meth-related deaths in 2016 in Texas, according to a study by the University of Texas at Austin.

The study also indicated how meth is more potent now than when it was previously formulated with pseudoephedrine — establishing a potency rating of 95 percent. Between 2014 and 2016, meth seizures went up by 103 percent.

In 2016, out of all addiction treatment admissions, 17 percent were related to meth.

https://www.drugaddictionnow.com/2018/06/25/houston-addic...